Join us for a virtual discussion, during National Diabetes Awareness Month, to explore the pharmacologic management of patients with both obesity and type 2 diabetes, with an emphasis on GLP-1 receptor agonists.                                     

The session will also highlight the crucial role of dietary and lifestyle strategies in supporting and enhancing outcomes.